Sen.
Passing legislation to address drug costs is challenging because of the pharmaceutical industry’s lobbying influence, but Congress could make inroads by harnessing public scrutiny, Sanders (I-Vt.) said Thursday at a press conference.
“One of the tools we have is public pressure,” Sanders said. “When the American people know what’s going on, it puts pressure on them that helps us lower the cost.”
The CEOs of
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.

